CLINICAL TRIAL: CRANIOSACRAL THERAPY IN MIGRAINE: FEASIBILITY STUDY

点击翻译按钮获取中文摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary aim of this study is to gather quality preliminary data on the usefulness of craniosacral therapy (CST) as an adjunct to conventional care for patients with migraine and to determine the feasibility of a larger, randomized clinical trial of CST in patients with migraine. Participants: Patients with migraine, with or without aura, under care of a neurologist. Procedures (methods): The study will compare CST to low-strength static magnets (attention-control complementary therapy) as a treatment for preventing migraine headaches. After an 8-week baseline period, participants will be randomized to one of two groups: 1) usual medical care plus 8 weeks of CST; or 2) usual medical care plus 8 weeks of attention-control complementary treatment. Primary outcome measures will include: 1) headache-related quality of life, 2) headache frequency, and 3) perceived benefit to receiving treatment. Duration of the study for each subject is 20 weeks. Length of the entire project is 2 years.